Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Accelerate DiagnosticsEyePoint PharmaceuticalsFluidigmHarvard BioscienceAstrotech
SymbolNASDAQ:AXDXNASDAQ:EYPTNASDAQ:FLDMNASDAQ:HBIONASDAQ:ASTC
Price Information
Current Price$8.06$9.37$4.63$6.97$1.20
52 Week RangeBuyBuyBuyBuyN/A
MarketRank™
Overall Score1.81.41.81.80.5
Analysis Score3.33.53.53.50.0
Community Score2.62.73.02.92.6
Dividend Score0.00.00.00.00.0
Ownership Score2.50.01.70.80.0
Earnings & Valuation Score0.60.60.61.90.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$17.50$17.88$12.00$9.00N/A
% Upside from Price Target117.12% upside90.77% upside159.18% upside29.12% upsideN/A
Trade Information
Market Cap$493.48 million$269.30 million$345.15 million$278.29 million$29.54 million
Beta2.351.621.871.73-0.78
Average Volume546,138367,8132,576,126215,5583,991,955
Sales & Book Value
Annual Revenue$9.30 million$20.36 million$117.24 million$116.18 million$490,000.00
Price / Sales53.0613.232.942.4060.28
CashflowN/AN/AN/A$0.56 per shareN/A
Price / CashN/AN/AN/A12.36N/A
Book Value($0.14) per share$0.77 per share$2.21 per share$2.15 per share$0.08 per share
Price / Book-57.5712.172.103.2415.00
Profitability
Net Income$-84,310,000.00$-56,790,000.00$-64,790,000.00$-4,690,000.00$-8,310,000.00
EPS($1.55)($4.80)($0.53)$0.12N/A
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/A46.47
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-697.50%-112.23%-37.85%-6.51%-1,332.38%
Return on Equity (ROE)N/A-434.26%-19.25%4.29%-1,607.31%
Return on Assets (ROA)-68.09%-53.01%-9.62%2.15%-164.60%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A6.69%0.36%0.53%0.53%
Current Ratio13.02%3.68%2.87%2.05%0.66%
Quick Ratio11.68%3.40%2.41%0.98%0.51%
Ownership Information
Institutional Ownership Percentage51.79%N/A88.30%64.87%2.95%
Insider Ownership Percentage44.40%33.89%2.20%5.40%30.00%
Miscellaneous
Employees2248462742827
Shares Outstanding61.23 million28.74 million74.55 million39.93 million24.61 million
Next Earnings Date5/6/2021 (Estimated)5/5/2021 (Estimated)5/6/2021 (Confirmed)5/4/2021 (Estimated)5/12/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable
SourceHeadline
Astrotech Hit With Derivative Suit Alleging Bogus Shares - Law360Astrotech Hit With Derivative Suit Alleging Bogus Shares - Law360
law360.com - April 16 at 8:01 PM
Penny Stocks To Watch With Cryptocurrency in Focus | FinancialContent Business Page - Financial ContentPenny Stocks To Watch With Cryptocurrency in Focus | FinancialContent Business Page - Financial Content
markets.financialcontent.com - April 16 at 3:01 PM
Square Stock - Astrotech Corporation (ASTC) and Square Inc. (SQ) – BOV News - Fintech ZoomSquare Stock - Astrotech Corporation (ASTC) and Square Inc. (SQ) – BOV News - Fintech Zoom
fintechzoom.com - April 15 at 1:44 AM
Is Astrotech a Good Aerospace Stock to Add to Your Portfolio? By StockNews - Investing.comIs Astrotech a Good Aerospace Stock to Add to Your Portfolio? By StockNews - Investing.com
investing.com - April 14 at 3:43 PM
Is Astrotech a Good Aerospace Stock to Add to Your Portfolio?Is Astrotech a Good Aerospace Stock to Add to Your Portfolio?
stocknews.com - April 14 at 2:58 PM
Astrotech Corporation (ASTC) investors to reap big returns againAstrotech Corporation (ASTC) investors to reap big returns again
marketingsentinel.com - April 14 at 12:41 AM
Take A Look At This Astrotech Corporation (NASDAQ:ASTC) Analysis Before You InvestTake A Look At This Astrotech Corporation (NASDAQ:ASTC) Analysis Before You Invest
stocksregister.com - April 14 at 12:41 AM
Astrotech Corporation [ASTC] Is Currently -17.69 below its 200 Period Moving Avg: What Dose This Mean?Astrotech Corporation [ASTC] Is Currently -17.69 below its 200 Period Moving Avg: What Dose This Mean?
dbtnews.com - April 14 at 12:41 AM
Is Astrotech (ASTC) Stock a Sell On Every Rise Now? – Own Snap - Own SnapIs Astrotech (ASTC) Stock a Sell On Every Rise Now? – Own Snap - Own Snap
ownsnap.com - April 13 at 2:39 PM
Astrotech Announces Closing of $37.3 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares - Yahoo TechAstrotech Announces Closing of $37.3 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares - Yahoo Tech
finance.yahoo.com - April 12 at 11:36 PM
Form 8-K ASTROTECH Corp For: Apr 07 - StreetInsider.comForm 8-K ASTROTECH Corp For: Apr 07 - StreetInsider.com
streetinsider.com - April 12 at 6:36 PM
Astrotech Announces Closing of $37.3 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares - Business WireAstrotech Announces Closing of $37.3 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares - Business Wire
businesswire.com - April 12 at 6:36 PM
Astrotech Announces Closing of $37.3 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional SharesAstrotech Announces Closing of $37.3 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
finance.yahoo.com - April 12 at 6:36 PM
Austin funding wrap: Disco Skincare, Astrotech, Peak Rock make moves - Austin Business JournalAustin funding wrap: Disco Skincare, Astrotech, Peak Rock make moves - Austin Business Journal
bizjournals.com - April 12 at 1:35 PM
Wall Street Futures Mostly Higher; Weekly Jobless Claims Rise - InvestorsObserverWall Street Futures Mostly Higher; Weekly Jobless Claims Rise - InvestorsObserver
investorsobserver.com - April 10 at 3:29 AM
Todays Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning - NasdaqToday's Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning - Nasdaq
nasdaq.com - April 10 at 3:29 AM
SOS : Thinking about buying stock in Safe-T Group, SOS Ltd, Astrotech, Immutep, or Zomedica? - Marketscreener.comSOS : Thinking about buying stock in Safe-T Group, SOS Ltd, Astrotech, Immutep, or Zomedica? - Marketscreener.com
marketscreener.com - April 8 at 3:45 PM
Embraer among industrial gainers; Astrotech and Apogee Enterprises among the losers - Seeking AlphaEmbraer among industrial gainers; Astrotech and Apogee Enterprises among the losers - Seeking Alpha
seekingalpha.com - April 8 at 3:45 PM
Astrotech Stock Price Fell Over 25% Pre-Market: Why It Happened - Pulse 2.0Astrotech Stock Price Fell Over 25% Pre-Market: Why It Happened - Pulse 2.0
pulse2.com - April 8 at 3:45 PM
Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning - InvestorPlaceToday’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning - InvestorPlace
investorplace.com - April 8 at 10:44 AM
Astrotech Increases Previously Announced Bought Deal Offering of Common Stock to $32.5 Million - Yahoo FinanceAstrotech Increases Previously Announced Bought Deal Offering of Common Stock to $32.5 Million - Yahoo Finance
finance.yahoo.com - April 8 at 10:44 AM
Best Penny Stocks To Buy Right Now? 5 Biotech Stocks For Your List - StreetInsider.comBest Penny Stocks To Buy Right Now? 5 Biotech Stocks For Your List - StreetInsider.com
streetinsider.com - April 7 at 10:34 PM
Other news to note for April 7, 2021 | 2021-04-07 - BioWorld OnlineOther news to note for April 7, 2021 | 2021-04-07 - BioWorld Online
bioworld.com - April 7 at 10:34 PM
Astrotech Increases Previously Announced Bought Deal Offering of Common Stock to $32.5 MillionAstrotech Increases Previously Announced Bought Deal Offering of Common Stock to $32.5 Million
finance.yahoo.com - April 7 at 10:34 PM
Astrotech to raise $10M in direct offering; stock down 22% - Seeking AlphaAstrotech to raise $10M in direct offering; stock down 22% - Seeking Alpha
seekingalpha.com - April 7 at 5:34 PM
DateCompanyBrokerageAction
11/6/2020Accelerate DiagnosticsPiper SandlerLower Price Target
10/7/2020Accelerate DiagnosticsBTIG ResearchInitiated Coverage
8/7/2020Accelerate DiagnosticsCraig HallumUpgrade
9/27/2019Accelerate DiagnosticsJPMorgan Chase & Co.Downgrade
8/9/2019Accelerate DiagnosticsPiper Jaffray CompaniesLower Price Target
3/1/2021EyePoint PharmaceuticalsCowenInitiated Coverage
1/29/2021EyePoint PharmaceuticalsHC WainwrightReiterated Rating
1/27/2021EyePoint PharmaceuticalsCantor FitzgeraldInitiated Coverage
1/12/2021EyePoint PharmaceuticalsB. RileyBoost Price Target
11/4/2019EyePoint PharmaceuticalsLaidlawInitiated Coverage
9/12/2019EyePoint PharmaceuticalsGuggenheimInitiated Coverage
8/27/2020FluidigmUBS GroupBoost Price Target
11/6/2019FluidigmJanney Montgomery ScottDowngrade
3/10/2021Harvard BioscienceKeyCorpBoost Price Target
1/7/2021Harvard BioscienceBenchmarkUpgrade
12/9/2020Harvard BioscienceNorthland SecuritiesInitiated Coverage
8/29/2018AstrotechChardan CapitalReiterated Rating
(Data available from 4/17/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.